Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies.

Pollack, Mark H; Meoni, Paolo; Otto, Michael W; Simon, Naomi; Hackett, David

Pollack, Mark H; Meoni, Paolo; Otto, Michael W; Simon, Naomi; Hackett, David.

Affiliation

Pollack MH; Department of Psychiatry, Anxiety Disorders Program, Massachusetts General Hospital, WAC-812, 15 Parkman Street, Boston, MA 02215, USA. mpollack@partners.org

J Clin Psychopharmacol ; 23(3): 250-9, 2003 Jun.

Article in En | MEDLINE | ID: mdl-12826987

Subject(s)

Anxiety Disorders/drug therapy; Anxiety Disorders/psychology; Cyclohexanols/administration & dosage; Diagnostic and Statistical Manual of Mental Disorders; Adolescent; Adult; Anxiety Disorders/diagnosis; Chi-Square Distribution; Confidence Intervals; Delayed-Action Preparations/administration & dosage; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Anxiety Disorders / Cyclohexanols / Diagnostic and Statistical Manual of Mental Disorders Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Psychopharmacol Year: 2003 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links